PLASMA OSTEOPROTEGERIN AS A MARKER OF DOCUMENTED CORONARY ATHEROSCLEROSIS IN TYPE TWO DIABETES MELLITUS PATIENTS


  • A.A. Kremzer Zaporozhye State Medical University, Ukraine
Keywords: Type two diabetes mellitus; Osteoprotegerin; Cardiovascular events; Coronary artery disease.

Abstract

PLASMA OSTEOPROTEGERIN AS A MARKER OF DOCUMENTED CORONARY ATHEROSCLEROSIS IN TYPE TWO DIABETES MELLITUS PATIENTS

References

1. Mori K., Jono S. Calcified coronary artery disease and serum markers. Clin Calcium. 2007; 17(3):340-345.

2. Tousoulis D., Siasos G., Maniatis K., Oikonomou E., Vlasis K., Papavassiliou A.G., Stefanadis C. Novel biomarkers assessing the calcium deposition in coronary artery disease. Curr. Med. Chem. 2012; 19(6): 901-920.

3. Rana J.S., Gransar H., Wong N.D., Shaw L., Pencina M., Nasir K., Rozanski A., Hayes S.W., Thomson L.E., Friedman J.D., Min J.K., Berman D.S. Comparative value of coronary artery calcium and multiple blood biomarkers for prognostication of cardiovascular events. Am. J. Cardiol. 2012; 109(10): 1449-1453.

4. Berezin AE. Can Osteoprotegerin be a Target of Therapy in Type 2 Diabetes Mellitus? Metabolomics. 2016; 6: 172-178
Published
2019-11-07
How to Cite
Kremzer, A. (2019). PLASMA OSTEOPROTEGERIN AS A MARKER OF DOCUMENTED CORONARY ATHEROSCLEROSIS IN TYPE TWO DIABETES MELLITUS PATIENTS. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 3(1), 100-101. https://doi.org/10.29256/v.03.01.2019.escbm69
Section
Selected abstracts